SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending due to rising market anxiety over significant AI disruption impacting software and cybersecurity stocks, coupled with escalating geopolitical tensions from potential new US tariffs and military action in Iran. The community is actively discussing impending NVDA earnings and Bitcoin volatility as key factors influencing the S&P 500's uncertain path.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc is actively discussed following a mixed earnings report, where an EPS beat was overshadowed by concerns over revenue growth and compressed margins, alongside escalating legal and regulatory challenges from Novo Nordisk, the FDA, DOJ, and SEC. Community sentiment is sharply divided, with some investors seeing a compelling buying opportunity due to perceived undervaluation and high short interest, while others highlight significant regulatory and legal risks predicting further declines.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending following a substantial sell-off after an Anthropic blog post highlighted its Claude AI's capability to automate COBOL modernization, fueling community debate over AI's disruptive impact on legacy services versus IBM's existing AI solutions and strategic partnerships.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Vir Biotechnology Inc

Vir Biotechnology is trending due to its global collaboration with Astellas on the VIR-5500 oncology program, which includes $335 million in upfront and near-term payments and up to $1.37 billion in potential milestones. This deal, coupled with positive Phase 1 clinical data, has the community buzzing about significant financial terms and a potential short squeeze, although some caution against a typical post-news pullback.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Quantum technology firm Infleqtion (INFQ) is a hot topic following its public listing and upcoming NYSE bell ringing, with investors debating its long-term potential as a leader in quantum computing and sensing, highlighted by strategic defense and NASA contracts and significant institutional investment, while navigating typical post-SPAC volatility.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal (PYPL) is trending following reports of unsolicited takeover interest, with potential suitors reportedly considering acquiring the entire company or specific assets like Venmo. The community is actively discussing the company's perceived undervaluation, anticipating a significant buyout premium given its robust financials and extensive user base.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk shares are sharply lower after its next-generation obesity drug, CagriSema, demonstrated less weight loss than Eli Lilly's rival in a head-to-head trial, sparking community debate over whether the efficacy difference justifies the steep sell-off. Many investors are viewing the decline as a potential buying opportunity, citing the company's strong fundamentals and the positive traction of its oral Wegovy pill in a rapidly expanding market.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending as a major sovereign wealth fund's significant investment counters recent short-seller allegations, fueling community discussion around its strategic acquisitions to become a full-stack quantum leader. This development, coupled with high short interest, is generating buzz about a potential squeeze amidst broader government focus on advancing quantum computing.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is experiencing an "AI scare trade" sell-off following a Citrini Research report suggesting AI agents could disrupt its core interchange revenue model, sparking widespread community debate. While some fear a paradigm shift for legacy finance, others are actively buying the dip, dismissing the threat as overblown given Mastercard's own AI integration efforts, strong earnings, and recent share repurchase program.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is a top trending stock as the bidding war for Warner Bros. Discovery reaches a critical juncture, with Paramount Skydance's enhanced offer pressuring Netflix to either significantly raise its bid or walk away. Investors are fiercely debating whether acquiring WBD's assets would cement Netflix's market position despite mounting regulatory scrutiny and debt concerns, or if walking away with a break-up fee is the more prudent move to bolster shareholder value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and FEED

NanoVibronix, Inc. (NASDAQ: NAOV) (NanoVibronix or the Company), a medical technology company specializing in non-invasive therapeutic systems, today announced that it will change its corporate name...

NanoVibronix Issues Letter to Shareholders

NanoVibronix, Inc. (NASDAQ: NAOV) ('NanoVibronix' or the 'Company'), a medical technology company specializing in non-invasive therapeutic systems, today issued a letter to shareholders, highlighting...

NanoVibronix (NAOV) announced on Monday that the United States Patent and Trademark Office issued a new patent on September 9 to its subsidiary, ENvue Medical Holdings LLC.The <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20250915498756/en/NanoVibronix-Announces-Grant-of-New-U.S.-Patent-Further-Expanding-ENvue-Medicals-Intellectual-Property-Portfolio">patent</a> protects the medical technology company’s proprietary systems and methods for guiding the insertion of medical devices such as feeding tubes using electromagnetic positioning technology. The invention seeks to reduce the risk of misplacement and associated complications. &nbsp;Shares of the company jumped 74% at the time of writing.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/NAOV">NAOV stock</a> jumped from ‘bullish’ to ‘extremely bullish’ territory over the last 24 hours, and message volume jumped from ‘normal’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:577/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_15_at_12_35_46_PM_png_4d270721a5.webp" alt="NAOV's Sentiment Meter and Message Volume as of 12:36 p.m. ET on Sept. 15 2025 | Source: Stocktwits" width="577" height="61"><figcaption>NAOV's Sentiment Meter and Message Volume as of 12:36 p.m. ET on Sept. 15 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user who profited from the rally said they are bullish on the stock.<stembedurl>https://stocktwits.com/YaBoy720/message/628708152</stembedurl>“We are continuing to build a robust and growing IP portfolio that not only protects our proprietary technology but also creates strong barriers to entry in our target markets,” said CEO Doron Besser about the recent patent grant.The CEO stated that the company is confident that ENvue is well-positioned as a leader in next-generation navigation and guidance systems for enteral feeding and other clinical applications, with multiple granted U.S. and international patents.Earlier this month, the company also announced a patent that protects its proprietary method of overlaying electromagnetic (EM) navigation data directly onto real-time medical imaging modalities, such as X-ray, CT, ultrasound, and MRI. The patent, it then said, protects key technology designed to help clinicians visualize the live path of a feeding tube or catheter directly on medical images.NAOV stock fell 83% this year and by 85% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/helius-medical-stock-rockets-after-company-raises-500-million-to-make-solana-its-primary-treasury-asset/chww0TVRdUY">Helius Medical Stock Rockets 169% After Company Raises $500M To Make Solana Its Primary Treasury Asset: Retail Cheers The Deal</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Why Did NanoVibronix Stock Jump A Whopping 74% Today?

The United States Patent and Trademark Office has issued a new patent to ENvue Medical Holdings, a subsidiary of the company.

Equity

Medical technology company NanoVibronix, Inc. (NAOV) on Wednesday <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.nanovibronix.com/news-releases/">announced</a> the retirement of Brian Murphy as CEO, effective immediately.The company announced that its board has appointed Doron Besser as the new chief executive, effective immediately. Besser is CEO of ENvue Medical Holdings, LLC, a wholly-owned subsidiary of NanoVibronix.Murphy, meanwhile, will remain on the company’s board as a director.NanoVibronix completed its acquisition of ENvue in February. Before that, ENvue was privately held and developed tube feeding solutions.Besser said that he believes the company is “well-positioned” to capitalize on new market opportunities and enhance its product portfolio following the combination of NanoVibronix and ENvue.Texas-based NanoVibronix develops both non-invasive and minimally invasive solutions for use in both clinical and home care settings. The company said on Wednesday that it will focus on the full-scale commercialization of existing technologies while developing new solutions.The company regained full compliance with Nasdaq’s listing requirements in April after announcing a reverse stock split to improve the stock price. Last month, the company also completed a $10 million public offering of preferred stocks and warrants.On Stocktwits, retail sentiment around NanoVibronix stayed unmoved within ‘extremely bullish’ territory over the past 24 hours while message volume was at ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:1260/134;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_04_at_2_14_35_PM_png_97c51e6894.webp" alt="NAOV's Sentiment Meter and Message Volume as of 2:20 p.m. ET on June 4, 2025 | Source: Stocktwits" width="1260" height="134"><figcaption>NAOV's Sentiment Meter and Message Volume as of 2:20 p.m. ET on June 4, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expressed disappointment over the stock’s lack of reaction on Wednesday.<stembedurl>https://stocktwits.com/JohnTuld01/message/616802707</stembedurl>Meanwhile, another opined that the CEO transition update was just the beginning. <stembedurl>https://stocktwits.com/pakman197/message/616800172</stembedurl><a href="https://stocktwits.com/symbol/NAOV">NAOV stock</a> is down by 85% this year and by about 88% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/trump-tax-bill-federal-deficit-2-4-trillion-cbo/chkuNruRbDe">Trump’s Tax Bill To Add $2.4 Trillion To Deficit, Not $3.8 Trillion, Says CBO</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

NanoVibronix Replaces CEO, Retail Believes This Was Only A ‘Starter’

The company said that its board has appointed Doron Besser as NanoVibronix’s new CEO.

ENvue Medical, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.

Current Price	$2.50
Prev Close	$2.75
Open	$2.70
Dividend Yield	0.00%
50-Day Moving Average	$2.62
Beta	0.63
Avg. Volume	26.77M
PE Ratio	-0.03

52-Week High	$162.50
52-Week Low	$0.99
Market Capitalization	$2.99M
EPS (Annual)	-$137.30
Price to Book	0.07
Revenue Per Employee	$82,516.13

NAOV
NanoVibronix Inc

Feed

News

Sentiment

Fundamentals

Info

Latest NAOV News

NAOVNanoVibronix Inc